Edwards Lifesciences Showcases Transcatheter Valve Repair Innovations at China's CIIE for Sixth Consecutive Year

Deep News

Nov 07

Edwards Lifesciences, a leader in structural heart disease treatments, made its sixth consecutive appearance at the China International Import Expo (CIIE) on November 7. The company displayed its comprehensive portfolio of cutting-edge valve replacement and repair solutions, featuring the mainland debut of its PASCAL Precision transcatheter valve repair system following its recent launch in Hong Kong, China. Edwards also announced upgraded strategic partnerships with key industry players including Sinopharm Group and Shanghai Pharmaceuticals.

Wayne Markowitz, Edwards' Global Vice President for Japan and Asia-Pacific, reaffirmed the company's commitment to accelerating the introduction and clinical adoption of advanced technologies in China through CIIE's open platform, guided by its "Patient First" philosophy.

Zhong Shunhe, Senior Vice President and General Manager of Edwards Greater China, highlighted that the PASCAL Precision system's CIIE debut post-Hong Kong launch demonstrates the rapid expansion of Edwards' transcatheter valve repair innovations into the Chinese market.

The PASCAL Precision system offers a minimally invasive treatment option for high-surgical-risk patients with mitral or tricuspid regurgitation. The product is expected to receive mainland China approval next year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1113813250"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1113813250\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1113813250?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 11:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113813250","market":"sg","top_or_hot":-1,"title":"Edwards Lifesciences Showcases Transcatheter Valve Repair Innovations at China's CIIE for Sixth Consecutive Year","media":"Deep News","content":"<p>Edwards Lifesciences, a leader in structural heart disease treatments, made its sixth consecutive appearance at the China International Import Expo (CIIE) on November 7. The company displayed its comprehensive portfolio of cutting-edge valve replacement and repair solutions, featuring the mainland debut of its PASCAL Precision transcatheter valve repair system following its recent launch in Hong Kong, China. Edwards also announced upgraded strategic partnerships with key industry players including Sinopharm Group and Shanghai Pharmaceuticals.</p>\n<p>Wayne Markowitz, Edwards' Global Vice President for Japan and Asia-Pacific, reaffirmed the company's commitment to accelerating the introduction and clinical adoption of advanced technologies in China through CIIE's open platform, guided by its \"Patient First\" philosophy.</p>\n<p>Zhong Shunhe, Senior Vice President and General Manager of Edwards Greater China, highlighted that the PASCAL Precision system's CIIE debut post-Hong Kong launch demonstrates the rapid expansion of Edwards' transcatheter valve repair innovations into the Chinese market.</p>\n<p>The PASCAL Precision system offers a minimally invasive treatment option for high-surgical-risk patients with mitral or tricuspid regurgitation. The product is expected to receive mainland China approval next year.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Edwards Lifesciences Showcases Transcatheter Valve Repair Innovations at China's CIIE for Sixth Consecutive Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEdwards Lifesciences Showcases Transcatheter Valve Repair Innovations at China's CIIE for Sixth Consecutive Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-11-07 11:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Edwards Lifesciences, a leader in structural heart disease treatments, made its sixth consecutive appearance at the China International Import Expo (CIIE) on November 7. The company displayed its comprehensive portfolio of cutting-edge valve replacement and repair solutions, featuring the mainland debut of its PASCAL Precision transcatheter valve repair system following its recent launch in Hong Kong, China. Edwards also announced upgraded strategic partnerships with key industry players including Sinopharm Group and Shanghai Pharmaceuticals.</p>\n<p>Wayne Markowitz, Edwards' Global Vice President for Japan and Asia-Pacific, reaffirmed the company's commitment to accelerating the introduction and clinical adoption of advanced technologies in China through CIIE's open platform, guided by its \"Patient First\" philosophy.</p>\n<p>Zhong Shunhe, Senior Vice President and General Manager of Edwards Greater China, highlighted that the PASCAL Precision system's CIIE debut post-Hong Kong launch demonstrates the rapid expansion of Edwards' transcatheter valve repair innovations into the Chinese market.</p>\n<p>The PASCAL Precision system offers a minimally invasive treatment option for high-surgical-risk patients with mitral or tricuspid regurgitation. The product is expected to receive mainland China approval next year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KWEB","symbol_name":"中国海外互联网ETF-KraneShares","start_time":0,"source_url":"","article_id":"1113813250","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113813250","pubTimestamp":1762485628,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Edwards Lifesciences, a leader in structural heart disease treatments, made its sixth consecutive appearance at the China International Import Expo (CIIE) on November 7. The company displayed its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"KWEB":"中国海外互联网ETF-KraneShares","DRAG":"中国龙ETF-Roundhill","HXC":"纳斯达克中国金龙指数","ASHS":"德银沪深中证500指数ETF","CHAU":"二倍做多沪深300(Direxion)","CQQQ":"中国科技指数ETF-Guggenheim","MCHI":"中国ETF-iShares MSCI","CWEB":"两倍做多沪深中国互联网股票ETF-Direxion","YINN":"三倍做多富时中国ETF-Direxion","BK4614":"Manus概念股","ASHR":"德银沪深300指数ETF","BK4588":"碎股","BK4585":"ETF&股票定投概念","FXI":"中国大盘股ETF-iShares"},"translate_title":"Edwards Lifesciences连续第六年在中国进博会上展示经导管瓣膜修复创新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASHR":1,"ASHS":1,"CHAU":1,"CQQQ":1,"CWEB":1,"DRAG":1,"FXI":1,"HXC":1,"KWEB":1,"MCHI":1,"YINN":1},"content_text":"Edwards Lifesciences, a leader in structural heart disease treatments, made its sixth consecutive appearance at the China International Import Expo (CIIE) on November 7. The company displayed its comprehensive portfolio of cutting-edge valve replacement and repair solutions, featuring the mainland debut of its PASCAL Precision transcatheter valve repair system following its recent launch in Hong Kong, China. Edwards also announced upgraded strategic partnerships with key industry players including Sinopharm Group and Shanghai Pharmaceuticals.\nWayne Markowitz, Edwards' Global Vice President for Japan and Asia-Pacific, reaffirmed the company's commitment to accelerating the introduction and clinical adoption of advanced technologies in China through CIIE's open platform, guided by its \"Patient First\" philosophy.\nZhong Shunhe, Senior Vice President and General Manager of Edwards Greater China, highlighted that the PASCAL Precision system's CIIE debut post-Hong Kong launch demonstrates the rapid expansion of Edwards' transcatheter valve repair innovations into the Chinese market.\nThe PASCAL Precision system offers a minimally invasive treatment option for high-surgical-risk patients with mitral or tricuspid regurgitation. The product is expected to receive mainland China approval next year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}